Rajiv Anand MD FRCS, MBA
Glaucoma Related, Retinal Disease
Partner, Texas Retina Associates
Join to view full profile
9600 N Central ExpySte 100Dallas, TX 75231
Phone+1 214-692-6941
Fax+1 214-363-2311
Dr. Anand is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1986 - 1988
Delhi University College of Medical SciencesClass of 1978
Certifications & Licensure
TX State Medical License 1989 - 2027
PA State Medical License 1987 - 1988
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014-2017
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
Publications & Presentations
PubMed
- 20 citationsSubretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results.Paul Yang, David Birch, Andreas Lauer, Robert Sisk, Rajiv Anand
American Journal of Ophthalmology. 2025-03-01 - 7 citationsTwo-year results for ranibizumab for radiation retinopathy (RRR): a randomized, prospective trialHannah J. Yu, Dwain G. Fuller, Rajiv Anand, Timothy Fuller, Jose Munoz
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2021-08-31 - 15 citationsRandomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes.Amy C Schefler, Dwain G. Fuller, Rajiv Anand, Timothy Fuller, Chelsey Moore
American Journal of Ophthalmology. 2020-08-01
Press Mentions
The Argus II Retinal Prosthesis SystemMay 16th, 2017- The Argus II Retinal Prosthesis SystemMay 16th, 2017
Repeated Intravitreal Injections Linked to GlaucomaMay 1st, 2017
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
